Unicycive Therapeutics UNCY Growth Metrics (2020-2026)

NASDAQ UNCY
$3.78 +0.12 (+3.28%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Unicycive Therapeutics Quarterly Growth Metrics

Periods 24 quarters
Latest Jun 2026

Unicycive Therapeutics reported asset growth of 46.55% for the quarter ended Jun 2026. These growth metrics cover 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Total Debt (QoQ)
-97.49%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
-18.71%1.38%-9.52%-25.94%-26.90%0.00%545.14%-40.80%-5.09%22.80%-5.62%-3.80%-3.26%1.42%27.67%6.58%-2.96%281.70%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
56.93%59.33%61.37%30.14%57.82%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
33.89%135.64%97.86%37.23%29.67%36.29%24.75%24.77%39.94%58.00%73.65%171.38%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
236.62%43.56%0.00%11.30%-50.34%-51.02%249.25%179.19%262.50%345.14%-34.88%5.82%7.85%-10.92%20.50%33.51%33.93%404.03%
Revenue Growth (1y)
0.00%
Return on Sales [ROS] (QoQ)ROS (QoQ)
-0.06M-0.17M-0.01M0.17M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
-0.23M-0.07M
Return on Equity [ROE] (QoQ)ROE (QoQ)
0.01M0.00M0.00M-0.01M-0.07M0.01M0.01M0.00M-55.000.00M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
-0.02M-0.01M0.01M0.08M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
-0.01M-0.08M0.02M0.01M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
0.00M0.00M0.00M-0.01M-0.03M-0.01M0.08M0.00M-0.02M0.01M0.00M0.01M0.00M-353.000.00M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
0.00M-0.02M-0.02M-0.01M0.01M0.05M0.01M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
-0.02M-0.05M-0.01M-0.01M0.01M0.03M0.06M-0.01M0.00M0.02M0.01M0.01M
Return on Assets [ROA] (QoQ)ROA (QoQ)
0.00M0.00M0.00M0.00M-0.01M0.02M0.01M0.00M0.00M0.00M0.00M-987.000.00M0.00M-240.000.00M0.00M647.00431.00
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
712.000.00M0.00M532.000.01M0.02M0.01M0.00M
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
-0.01M-0.02M-0.01M0.00M0.00M0.02M0.01M0.00M0.00M0.00M0.00M0.00M-842.000.00M0.00M0.01M
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
0.00%-7.14%-7.69%-8.33%-4.55%42.86%-6.67%-7.14%-11.54%86.96%41.86%22.95%10.67%0.00%-9.64%-12.00%-27.27%-14.58%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
38.88%43.65%47.24%46.20%44.22%31.73%10.97%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
-21.43%-25.00%15.38%16.67%18.18%9.52%43.33%117.86%188.46%260.87%93.02%22.95%-12.00%-42.17%-50.60%
Operating Margin Growth (1y)
-0.07M
Operating Income (QoQ)Op. Inc (QoQ)
-505.26%41.63%-28.52%-2.80%-52.75%4.12%21.09%-2.86%-37.39%-6.32%-45.79%19.59%15.54%-48.15%13.74%12.84%-5.44%1.61%-16.79%-20.18%
Operating Income Growth (5y)Op. Inc Growth (5y)
-83.35%-63.62%-58.73%-63.10%-67.07%
Operating Income Growth (3y)Op. Inc Growth (3y)
-134.31%-111.68%-106.49%-132.64%-111.80%-9.86%-49.85%-31.21%-24.18%-9.75%-10.70%-26.16%-32.88%
Operating Income Growth (1y)Op. Inc Growth (1y)
-653.19%-283.82%-383.86%-366.75%-17.79%-93.50%-18.80%-18.87%-6.91%-18.55%-119.04%-71.24%-5.27%-46.70%13.20%5.92%-17.45%22.00%-5.61%-45.63%
Net Margin Growth (1y)
-0.09M
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
-372.82%47.09%-28.52%-2.80%-52.83%4.12%-177.16%69.93%0.81%-77.03%-171.49%34.97%70.25%-425.51%71.13%-3.75%6.76%-144.02%12.57%86.57%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-80.34%-53.65%-75.54%-67.80%-9.38%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-135.97%-84.45%-106.93%-180.04%-132.18%7.65%-98.50%-20.66%-21.04%-2.65%-40.15%4.59%27.08%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-640.88%-212.73%-266.91%-230.55%-6.84%-93.60%-317.50%-22.14%20.73%-46.36%-43.37%-210.00%7.01%-176.03%70.65%53.17%-46.75%31.86%-106.37%73.29%
Net Income (QoQ)
-372.82%47.09%-28.52%-2.80%-52.83%4.12%-173.55%73.67%-12.90%-79.97%-168.83%147.01%-141.56%-425.51%102.65%-1,231.05%6.76%-144.02%12.58%86.57%
Net Income Growth (5y)
-80.34%-53.65%-75.54%-67.80%-9.38%
Net Income Growth (3y)
-124.77%-83.44%-106.93%-179.12%122.12%7.65%-98.50%29.29%-21.04%-2.65%-40.15%4.18%23.44%
Net Income Growth (1y)
-640.88%-212.73%-266.91%-230.55%-6.84%-93.60%-312.07%-5.56%22.03%-46.36%-43.83%356.77%5.47%-176.03%102.72%-165.42%-46.75%31.86%-2,349.65%73.29%
Net Cash Flow (QoQ)NCF (QoQ)
12,435.62%-107.79%-110.91%-2.97%-16.93%-70.75%492.46%-123.04%18.70%-3.82%944.72%-118.23%-31.93%34.22%-2.71%140.14%696.25%-166.27%160.55%-16.63%
Net Cash Flow Growth (5y)NCF Growth (5y)
218.65%-192.54%123.36%117.50%
Net Cash Flow Growth (3y)NCF Growth (3y)
-320.11%-319.29%543.82%-265.86%-36.15%-64.15%-29.14%41.61%97.61%-30.42%-30.05%47.95%
Net Cash Flow Growth (1y)NCF Growth (1y)
28,948.39%-2,126.98%-2,112.93%-1,986.99%-119.78%-333.64%906.93%-80.57%-25.54%23.67%64.30%-29.95%-110.89%-33.61%-116.25%135.78%315.92%-117.52%228.24%166.38%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
-3,432.54%19.30%-16,244.28%4.12%80.27%61.43%-144.25%-0.72%-38.50%-0.51%9.91%-11.11%-15.02%-0.57%8.62%45.34%-110.22%
Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y)
-26.10%-126.36%-127.41%-186.76%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
7.02%-242.14%-322.72%-441.35%-475.50%-69.40%-236.04%-261.61%35.82%46.78%-17.11%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
-940.78%-383.86%-366.75%-2,059.56%-2,394.83%-1,092.38%82.18%81.28%-31.42%-242.48%-26.33%-39.36%-15.73%-15.79%-17.45%42.22%-5.61%
Income After Tax (QoQ)
-333.64%42.31%-37.68%-4.43%-40.43%4.12%21.17%1.90%-39.05%-8.08%-47.85%24.03%15.89%-53.28%13.26%12.30%-3.77%2.51%-16.78%-20.36%
Income After Tax Growth (5y)
-82.38%-58.75%-50.96%-52.31%-54.55%
Income After Tax Growth (3y)
-130.14%-101.33%-91.62%-110.39%-84.91%-7.04%-48.25%-27.09%-19.90%-8.40%-9.00%-24.26%-33.03%
Income After Tax Growth (1y)
-579.49%-212.73%-285.45%-259.73%-16.50%-93.60%-10.85%-4.12%-3.10%-16.22%-117.98%-68.81%-2.11%-44.82%15.04%1.93%-20.99%23.05%-3.60%-42.19%
Free Cash Flow (QoQ)FCF (QoQ)
-1,500.92%59.61%-110.91%-2.97%-16.93%-70.75%35.57%-40.36%19.63%-0.38%-45.57%1.90%-46.33%29.17%-35.75%5.53%29.22%-34.67%22.20%-21.67%
Free Cash Flow Growth (5y)FCF Growth (5y)
-53.23%-71.72%-56.16%-103.66%
Free Cash Flow Growth (3y)FCF Growth (3y)
-84.33%-102.07%-112.54%-207.98%-38.73%-67.30%-44.45%-40.36%-18.73%-9.70%-16.82%-11.38%
Free Cash Flow Growth (1y)FCF Growth (1y)
-392.07%-160.78%-339.67%-1,304.15%-2.56%-333.64%-32.48%-80.57%-24.11%27.04%-64.85%-15.21%-109.77%-48.01%-38.02%-32.92%35.71%-22.25%29.94%9.77%
FCF Margin Growth (1y)
-0.04M
EPS (Diluted) (QoQ)
-192.74%35.80%-0.01%-2.63%-52.49%4.09%-173.97%69.93%53.69%-135.41%-90.83%75.86%68.54%-597.78%84.38%-4.44%36.51%-177.48%41.90%88.07%
EPS (Diluted) Growth (5y)
-5.63%16.60%2.26%13.75%44.85%
EPS (Diluted) Growth (3y)
-94.13%-17.86%-45.33%-75.39%-5.29%49.94%-10.88%40.29%39.94%55.16%36.10%61.89%72.00%
EPS (Diluted) Growth (1y)
-345.25%-127.66%-109.72%-92.92%-0.50%-50.13%-311.26%-20.49%63.41%10.20%37.45%49.79%65.88%-1.12%91.72%64.20%27.75%71.27%-6.89%87.79%
EPS (Basic) (QoQ)
-192.74%35.80%-0.01%-2.63%-52.49%4.09%-173.97%69.93%53.69%-135.41%-90.83%40.12%87.32%-597.78%83.45%1.48%36.51%-177.48%41.90%88.07%
EPS (Basic) Growth (5y)
-5.63%16.60%2.26%13.75%44.85%
EPS (Basic) Growth (3y)
-94.13%-17.86%-45.33%-75.39%-42.53%49.94%-10.88%39.12%39.94%55.16%36.10%61.89%72.00%
EPS (Basic) Growth (1y)
-345.25%-127.66%-109.72%-92.92%-0.50%-50.13%-311.26%-20.49%63.41%10.20%37.45%-24.56%65.88%-1.12%91.23%85.57%27.75%71.27%-0.84%87.79%
EBT (QoQ)
-333.64%42.31%-37.68%-4.43%-40.43%4.12%21.17%1.90%-39.05%-8.08%-47.85%24.03%15.89%-53.28%13.26%12.30%-3.77%2.51%-16.78%-20.36%
EBT Margin Growth (1y)
-0.07M
EBT Growth (5y)
-82.38%-58.75%-50.96%-52.31%-54.55%
EBT Growth (3y)
-130.14%-101.33%-91.62%-110.39%-84.91%-7.04%-48.25%-27.09%-19.90%-8.40%-9.00%-24.26%-33.03%
EBT Growth (1y)
-579.49%-212.73%-285.45%-259.73%-16.50%-93.60%-10.85%-4.12%-3.10%-16.22%-117.98%-68.81%-2.11%-44.82%15.04%1.93%-20.99%23.05%-3.60%-42.19%
EBIT (QoQ)
-505.26%41.63%-28.52%-2.80%-52.75%4.12%21.09%-2.86%-37.39%-6.32%-45.79%19.59%15.54%-48.15%13.74%12.84%-5.44%1.61%-16.79%-20.18%
EBIT Margin Growth (1y)
-0.07M
EBIT Growth (5y)
-83.35%-63.62%-58.73%-63.10%-67.07%
EBIT Growth (3y)
-134.31%-111.68%-106.49%-132.64%-111.80%-9.86%-49.85%-31.21%-24.18%-9.75%-10.70%-26.16%-32.88%
EBIT Growth (1y)
-653.19%-283.82%-383.86%-366.75%-17.79%-93.50%-18.80%-18.87%-6.91%-18.55%-119.04%-71.24%-5.27%-46.70%13.20%5.92%-17.45%22.00%-5.61%-45.63%
EBITDA Margin Growth (1y)
-0.07M
Dividends payables (QoQ)
314.06%9.06%0.00%-76.01%-99.52%
Dividends payables Growth (1y)
8.33%-99.87%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
-1,500.92%59.61%-110.76%-3.04%-16.93%-70.75%35.57%-40.36%19.63%-0.38%-45.44%2.12%-46.42%29.23%-35.97%5.43%29.19%-34.72%22.30%-21.84%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-53.22%-71.72%-56.12%-103.67%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-84.33%-102.07%-112.48%-207.65%-38.61%-67.12%-44.40%-40.33%-18.72%-9.70%-16.77%-11.39%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-392.07%-160.78%-339.38%-1,304.15%-2.56%-333.64%-32.57%-80.57%-24.11%27.04%-64.69%-14.85%-109.23%-47.51%-37.90%-33.25%35.56%-22.66%29.90%9.69%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
-233.33%-20.00%8.33%27.27%62.50%66.67%-603,450.00%57.29%99.55%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
-100.00%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
-166.67%70.00%91.67%-54,768.18%-32,118.75%-283.33%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
1,801,000.00%-7.95%-17.85%-22.37%-33.70%-93.51%5,247.69%-22.66%-23.77%-32.37%404.38%-14.61%-22.58%-19.18%-24.38%12.94%91.23%-31.61%27.99%18.23%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
749.29%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
3,369.95%21.55%16.39%13.22%28.30%82.62%300.36%15.38%32.91%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
1,057,200.00%-61.08%-97.26%78.65%77.98%104.64%2,032.09%101.09%122.02%125.49%169.48%-59.60%-46.56%31.99%11.69%89.04%97.90%
Capital Expenditures (QoQ)Capex (QoQ)
233.33%20.00%-8.33%-27.27%-62.50%-66.67%-112.50%
Capital Expenditures Growth (3y)Capex Growth (3y)
100.00%
Capital Expenditures Growth (1y)Capex Growth (1y)
166.67%-70.00%-91.67%-50.00%-116.67%
Assets (QoQ)
2,066.70%-5.25%-15.92%-18.68%-20.59%-72.31%865.29%-15.88%-15.04%-27.01%269.14%-14.67%-13.71%-17.90%-11.75%7.33%68.73%-2.92%31.08%11.84%
Assets Growth (5y)
199.47%139.56%
Assets Growth (3y)
311.27%265.83%24.93%19.10%21.04%32.77%70.69%159.31%33.28%46.55%
Assets Growth (1y)
9,088.24%1,303.72%-48.55%-84.97%72.60%78.55%91.04%403.58%92.58%95.35%98.41%123.16%-46.65%-32.90%31.20%55.16%130.46%140.14%

Unicycive Therapeutics Growth Metrics API

Pull Unicycive Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=UNCY&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY